analyst
IN
NASDAQ · INTS
Intensity Therapeutics, Inc.
Healthcare · Biotechnology
$3.50
Up+$0.12 (+3.55%)
Updated Nov 5, 2026, 5:27 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 28.29M
- P/E ratio
- -2.2
- Dividend yield
- 0.00%
- 52-week range
- $3.00 – $7.96
- Volume
- 6.74K
- Avg. volume
- 30.71M
Price performance · INTS
INTS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
INTS closed at $3.50 after 21 trading sessions, down 7.89% for the selected period.
- Last close
- $3.50
- Period change
- -7.89%
- Period low
- $3.14
- Period high
- $3.80
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $3.30 | $3.5758 | $3.30 | $3.50 | 6.74K |
| Nov 3, 2026 | $3.23 | $3.3999 | $3.19 | $3.38 | 5.79K |
| Nov 2, 2026 | $3.41 | $3.50 | $3.2309 | $3.43 | 5.6K |
| Oct 30, 2026 | $3.41 | $3.455 | $3.21 | $3.40 | 16.12K |
| Oct 29, 2026 | $3.43 | $3.43 | $3.1395 | $3.34 | 7.65K |
| Oct 28, 2026 | $3.21 | $3.38 | $3.21 | $3.38 | 1.42K |
| Oct 27, 2026 | $3.15 | $3.27 | $3.10 | $3.18 | 15.31K |
| Oct 26, 2026 | $3.20 | $3.24 | $3.00 | $3.20 | 10.28K |
| Oct 23, 2026 | $3.14 | $3.31 | $3.14 | $3.25 | 6.41K |
| Oct 22, 2026 | $3.22 | $3.5094 | $3.09 | $3.19 | 6.84K |
| Oct 21, 2026 | $3.25 | $3.51 | $3.13 | $3.1425 | 9.85K |
| Oct 20, 2026 | $3.31 | $3.31 | $3.25 | $3.28 | 2.59K |
| Oct 19, 2026 | $3.21 | $3.295 | $3.15 | $3.29 | 7.19K |
| Oct 16, 2026 | $3.40 | $3.40 | $3.14 | $3.35 | 32.31K |
| Oct 15, 2026 | $3.35 | $3.55 | $3.35 | $3.38 | 8.35K |
| Oct 14, 2026 | $3.56 | $3.58 | $3.2934 | $3.42 | 25.9K |
| Oct 13, 2026 | $3.20 | $4.04 | $3.0972 | $3.55 | 123.76K |
| Oct 12, 2026 | $3.70 | $3.70 | $3.14 | $3.31 | 41.99K |
| Oct 9, 2026 | $3.75 | $3.75 | $3.5501 | $3.63 | 16.72K |
| Oct 8, 2026 | $3.76 | $3.80 | $3.58 | $3.68 | 19.24K |
| Oct 7, 2026 | $3.47 | $3.87 | $3.4633 | $3.80 | 17.44K |
Latest INTS news
The latest Smart Investors Daily articles mentioning INTS.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

